Meridien Research
Meridien Research is a U.S. clinical research organization founded in 2000 in Winter Park, Florida, conducting clinical trials for pharmaceutical and biotech sponsors across a broad therapeutic range, operating within the Alcanza Clinical Research multisite network of 26 facilities.
- Company typePrivate
- Founded2000
- HeadquartersWinter Park, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Meridien Research does
Meridien Research is a U.S. clinical research organization founded in 2000, headquartered in Winter Park, Florida, and operating within the broader Alcanza Clinical Research multisite network. The company conducts clinical trials on behalf of pharmaceutical and biotech sponsors, enrolling patients across an extensive therapeutic range spanning oncology, central nervous system disorders, cardiometabolic conditions, vaccines, women's health, dermatology, and many other indications. Meridien recruits patients through a community-led, direct-to-patient model that combines community-based outreach, health education, and medical provider referrals, supported by a website-based profile creation and trial finder system.
The company's underlying technology layer includes the ReachOne AI Toolbox, an AI-powered product offering hosted at reachone.ai that supports clinical research patient engagement and education. Meridien is part of the Alcanza network, which operates 26 dedicated clinical research facilities across 14 U.S. states and Puerto Rico and is a founding member of the Association of Multisite Research Corporations (AMRC), an alliance of 14 multisite research organizations spanning 400+ sites and nearly 1,000 Principal Investigators.
Meridien's revenue model is professional services: the company earns fees from pharmaceutical and biotech sponsors for patient enrollment, study execution, and data collection across all major therapeutic areas. Patient participation is offered at no cost with compensation for time and travel. Praveen Asthana serves as Founder and CEO. Specific sponsor client names, contract values, and revenue figures are not publicly disclosed.
Meridien Research firmographics
Firmographics- Name
- Meridien Research
- Legal name
- Alcanza Clinical Research
- Website
- https://meridienresearch.net
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Meridien Research is a U.S. clinical research organization founded in 2000 in Winter Park, Florida, conducting clinical trials for pharmaceutical and biotech sponsors across a broad therapeutic range, operating within the Alcanza Clinical Research multisite network of 26 facilities.
- Ownership category
- akta.pro rank
Meridien Research industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industries
- Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG), Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC)
Keywords
Where Meridien Research is headquartered
LocationHeadquarters
- HQ city
- Winter Park
- HQ country
- United States
- HQ region
- North America
Offices26 records
Markets served
Meridien Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Research Services: Alcanza generates revenue by conducting clinical trials on behalf of pharmaceutical and biotech sponsors. The company provides research services to a diverse patient population across all major therapeutic areas, earning fees for patient enrollment, study execution, and data collection.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Meridien Research product offering
Product offeringCore offering
Meridien Research operates a dedicated clinical research facility in Winter Park that conducts clinical trials on behalf of pharmaceutical and biotech sponsors. As a member site of the Alcanza Clinical Research network, it recruits and enrolls diverse patient populations across multiple therapeutic areas, executes study protocols, and collects clinical data for sponsors while providing participants with access to investigational treatments.
Product overview
Alcanza Clinical Research is a clinical research organization providing inclusive clinical trial services. The company operates a network of dedicated clinical research facilities across the United States. Their main offering consists of clinical research services for patient participation in clinical trials, supplemented by the ReachOne AI Toolbox which appears to be an AI-powered patient engagement product. They collaborate with medical providers and community-based organizations to deliver clinical research opportunities.
Differentiator
Problem solved
Functional benefit
Brands
- ReachOne AI Toolbox: AI-powered toolbox referenced as a product offering on the company's website
Products and services
- Clinical Trial Participation Participation in clinical research studies across all major therapeutic areas, offered to patients and healthy volunteers at no cost with compensation for time and travel. Served through Meridien Research's Winter Park, FL site within the Alcanza Clinical Research network.
- Clinical Research Services for Sponsors Site-based clinical trial execution on behalf of pharmaceutical and biotech sponsors, including patient enrollment, study execution, and data collection across diverse therapeutic areas and patient populations.
Quantifiable outcome
- 73,500+ patients enrolled in 2024 across AMRC network
Companies that use Meridien Research
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles2 records
Meridien Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Meridien Research partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Association of Multisite Research Corporations (AMRC)coreAlcanza Clinical Research is a founding member of AMRC, a newly launched alliance of 14 prominent multisite research organizations. AMRC aims to transform clinical trial execution across the U.S. through collaboration, standardization, and data quality improvement. The network includes 400+ research sites, nearly 1,000 Principal Investigators, and 7,000+ research professionals. AMRC's mission includes minimizing delays impacting nearly 80% of clinical trials, improving operational efficiency for complex study designs, and strengthening collaboration to speed drug development.
Scale indicators5 records
Recent moves4 records
Expansion highlights5 records
Meridien Research competitors and assessment
Company assessmentBroad incumbents
- Alcanza Clinical Research: Parent multi-site clinical research network operating 26 sites across 14 states plus Puerto Rico. Meridien Research operates under the Alcanza banner, making Alcanza the direct operational umbrella and closest comparable for site-level activity.
- IQVIA: Largest global CRO with integrated site network. Operates as a broad incumbent whose site-management offerings overlap with Meridien's SMO services, serving the same pharma/biotech sponsors.
- Medpace: Mid-to-large global CRO running clinical trials across all major therapeutic areas. A broad incumbent whose site-management and full-service CRO offerings overlap with SMO activities.
- ICON plc: Global CRO with post-PPD acquisition site relationships across the US. A broad incumbent with site-management capabilities and large sponsor contracts that overlap with Alcanza/Meridien's service offering.
Direct peers
- Velocity Clinical Research: One of the largest integrated SMO networks in the US, operating dedicated clinical research sites across multiple states. Competes with Alcanza/AMRC-affiliated sites for the same sponsor trial placements and patient populations.
- Wake Research: Multi-site clinical research organization based in the southeastern US operating across therapeutic areas. Direct SMO peer with overlapping therapeutic breadth and community-based recruitment approach.
- Flourish Research: Multi-site clinical research organization with sites across the southeastern US. Directly comparable SMO serving the same sponsors, therapeutic categories, and patient populations.
- Benchmark Research: Multi-site SMO focused on phase II–IV clinical trials across diverse therapeutic areas. Operates dedicated research sites competing for sponsor trial allocations, with similar community-outreach patient recruitment model.
- Accel Research: Network of dedicated clinical research sites in the southeastern US covering multiple therapeutic areas. Operates with comparable patient-recruitment motion and sponsors across the same indications as Meridien.
- Research Across America: Multi-site SMO operating research facilities across multiple US states, primarily in the South and Midwest. Competes for sponsor trial placements with the same therapeutic-area breadth.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Meridien Research social profiles
Digital presenceMeridien Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Meridien Research leadership team
Management profileNumber of profiles
Profiles1 record
Meridien Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Meridien Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Meridien Research
What does Meridien Research do?
Meridien Research operates a dedicated clinical research facility in Winter Park that conducts clinical trials on behalf of pharmaceutical and biotech sponsors. As a member site of the Alcanza Clinical Research network, it recruits and enrolls diverse patient populations across multiple therapeutic areas, executes study protocols, and collects clinical data for sponsors while providing participants with access to investigational treatments.
Is Meridien Research a public or private company?
Meridien Research is a private company. It is classified as unknown and is currently operating.
When was Meridien Research founded?
Meridien Research was founded in 2000. It employs 51 to 100 people.
Where is Meridien Research based?
Meridien Research is headquartered in Winter Park, United States, in the North America region.
How does Meridien Research make money?
One revenue line is on record: clinical Research Services.
Who are Meridien Research's main competitors?
Broad incumbents on record are Alcanza Clinical Research, IQVIA, Medpace and ICON plc. Direct peers are Velocity Clinical Research, Wake Research, Flourish Research, Benchmark Research, Accel Research and Research Across America.
Does Meridien Research have an API?
No public API is recorded for Meridien Research.
What industry is Meridien Research in?
Meridien Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGACAG, Clinical Trial Monitoring Support (On-site/Remote). Its NAICS code is 5417 and its SIC code is 8731.